“vedanta-biosciences” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease 06/10/19 Boston
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes 05/30/19 San Francisco
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Gates Foundation, Bristol-Myers Join $27M Funding for Vedanta Bio 12/24/18 Boston
Microbiome Startup uBiome Expands into Drug Research with $83M 09/21/18 San Francisco
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Vedanta Biosciences Receives $50,000,000 New Financing 06/07/16 Boston
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Probing Gut Microbiome, Second Genome Nabs $43M To Push Colitis Drug 04/20/16 San Francisco
East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More 04/01/16 Boston
New PureTech Startup Commense Aims to Protect Babies From Disease 03/31/16 Boston
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Evelo Launches With $35M To Fight Cancer With Cocktails of Bacteria 11/04/15 Boston
To Back Startups, PureTech Heads Across the Pond For $160M London IPO 05/26/15 Boston
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
With Vedanta Deal, J&J Marks Big-Pharma Milestone in the Microbiome 01/13/15 Boston
Second Genome Has Begun First Drug Trial Based on Microbiome Secrets 01/12/15 San Francisco
With Invesco’s Support, PureTech Boosts Power to Back Startups 10/20/14 Boston
J&J Immunology Exec on Investing at the Crossroads of the Microbiome 07/24/14 National
Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs 07/22/14 Boston
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
Microbiome Startup Seres Health Tabs Pharma Vet Pomerantz as CEO 06/02/14 Boston
Page 1 of 2 next page »